ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,468.79
      0.20%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. ETFs
      4. USA
      5. AMEX
      6. Harbor Multi asset Explorer ETF (MAPP)

      7. Harbor Multi asset Explorer ETF (MAPP) News

      MAPP

      Harbor Multi asset Explo... (MAPP)

      Harbor Multi asset Explorer ETF
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:MAPP
      DateTimeSourceHeadlineSymbolCompany
      2:15PMiHub NewswireFeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
      02/16/20107:00AMPR Newswire (US)MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics TrialNYSE:MAPP
      01/06/20107:00AMPR Newswire (US)MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferenceNYSE:MAPP
      11/12/20097:00AMPR Newswire (US)MAP Pharmaceuticals Secures $60 Million Committed Equity Financing FacilityNYSE:MAPP
      11/11/20097:00AMPR Newswire (US)MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare ConferenceNYSE:MAPP
      10/29/20097:00AMPR Newswire (US)MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 PatientsNYSE:MAPP
      09/10/20097:00AMPR Newswire (US)MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of NYSE:MAPP
      09/02/20097:00AMPR Newswire (US)MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific ConferencesNYSE:MAPP
      07/09/20099:40AMDow Jones NewsAstraZeneca Terminates MAP Pharma Pact, Sees $44 Million charge In 2QNYSE:MAPPMAP Pharmaceuticals Inc.
      07/09/20098:30AMPR Newswire (US)MAP Pharmaceuticals Announces Termination of Pediatric Asthma CollaborationNYSE:MAPP
       Showing the most relevant articles for your search:AMEX:MAPP